Professor Andrew Briggs

BSc (Hons) MSc DPhil


15-17 Tavistock Place
United Kingdom

Professor of Health Economics at the London School of Hygiene & Tropical Medicine, and co-Director of the Global Health Economics Centre at the school, along with Anna Vassall and Mark Jit.  I  previously held the William R Lindsay Chair in Health Economics at the University of Glasgow.  Following a sabbatical at Memorial Sloan Kettering Cancer Center, New York in 2016/17, I remain a Visiting Investigator, collaborating with Dr Peter Bach on value frameworks for oncology medications.

I have  co-authored two textbooks, one published by OUP entitled Decision Modelling for Health Economic Evaluation, and the other published by Wiley entitled Statistical Methods for Cost-Effectiveness Analysis.

I am also Series Editor for OUP's Handbooks in Health Economic Evaluation series.

A link to my GooGle Scholar page:


Faculty of Public Health and Policy
Department of Health Services Research and Policy


Centre for Statistical Methodology
Global Health Economics Centre


Our highly successful Foundations and Advanced Decision Modelling for Health Economic Evaluation courses have been developed for online delivery and include, as a new element for 2021, the ability to follow the practical exercises in the statistical package R as well as in Excel.

For full details and to book a place on the upcoming courses in May and June 2022, please visit the course website.


My main methodological focus of research has been health economic evaluation, particularly statistical methods for cost-effectiveness analysis.  This includes statistical methods for estimation of parameters for cost-effectiveness models as well as statistical analysis of cost-effectiveness alongside clinical trials.  I have a more general interest in epidemiological methods, in particular the use of prognostic scoring methods for predicting health outcomes and the relationship with heterogeneity in cost-effectiveness analysis.

Research Area
Decision analysis
Economic evaluation
Randomised controlled trials
Health economics
United Kingdom
United States of America
South Africa
European Union
North America
Sub-Saharan Africa (all income levels)

Selected Publications

Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study.
Bidulka P; Mathur R; Lugo-Palacios DG; O'Neill S; Basu A; Silverwood RJ; Charlton P; Briggs A; Smeeth L; Adler AI
Diabetes, obesity & metabolism
Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up.
Chaudhary MA; Edmondson-Jones M; Baio G; Mackay E; Penrod JR; Sharpe DJ; Yates G; Rafiq S; Johannesen K; Siddiqui MK
Medical decision making : an international journal of the Society for Medical Decision Making
How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?
Cowie MR; Bozkurt B; Butler J; Briggs A; Kubin M; Jonas A; Adler AI; Patrick-Lake B; Zannad F
International journal of cardiology
Health Economic Evaluation Using Markov Models in R for Microsoft Excel Users: A Tutorial.
Green N; Lamrock F; Naylor N; Williams J; Briggs A
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations
Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E
Health policy open
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease: A Health-Economic Analysis of DAPA-CKD.
McEwan P; Darlington O; Miller R; McMurray JJV; Wheeler DC; Heerspink HJL; Briggs A; Bergenheim K; Garcia Sanchez JJ
Clinical journal of the American Society of Nephrology : CJASN
See more Publications